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Objective: To evaluate the other pharmacological actions of silymarin in Albino rats and
mice such as antipyretic, anti-inﬂammatory, antinociceptive and antihyperlipidemic
effects.
Methods: Rats were injected intramuscularly with pyrogenic dose of brewer's yeast for
the antipyretic test of silymarin. Another group of rats injected with 0.1 mL of 1%
carrageenan solution in saline at the subplanter area of the right hind paw for the anti-
inﬂammatory test of silymarin. Another group of mice tested by hot plate method for
determination of antinociceptive effect of silymarin. Hyperlipidemia was induced using
high fat diet for 2 months to estimate the antihyperlipidemic activity of silymarin.
Results: Silymarin showed a signiﬁcant antipyretic effect of both doses (50 and 100 mg/
kg) compared with control untreated group. Moreover, silymarin elucidated a signiﬁcant
anti-inﬂammatory effect of both doses reﬂected on the decrease of the rat paw edema
every hour interval for 4 h after administration in comparison with control positive group.
By the same taken, both doses of silymarine revealed a signiﬁcant antinociceptive action
in hot plate method at 30 and 60 min post administration. Besides, it lowered signiﬁcantly
the serum levels of prostaglandin E2, tumor necrosis factor alpha and interleukin 1 beta
after 2 h of silymarin administration in carrageenan induced rat paw edema besides the
signiﬁcant decrease of total cholesterol, triglycerides, low density lipoprotein and
signiﬁcantly elevated high density lipoprotein after 2 weeks of silymarin administration.
Conclusions: These outcomes delivered a new vision into the possible pharmacological
mechanisms by which silymarin advances antipyretic, anti-inﬂammatory, antinociceptive
and antihyperlipidemic effects.1. Introduction
Silymarin is a ﬂavonolignan that has been presented fairly
recently as a hepatic protective agent. It is extracted from the seeds
and fruit of Silybummarianumwith its active component silibinin.
Silymarin is used for the treatment of various liver disorders
manifested by progressive necrosis and functional deﬁciency [1,2].
Furthermore, it is able to afford liver protection against damages
(ischemia, radiation, iron load and viral hepatitis) [3].
Silymarine, is a well-known natural antioxidant product and
it had been used in many oxidative stress models in rats, besides
its immunomodulatory effects on prostaglandin E2 (PGE2), tu-
mor necrosis factor alpha (TNF-a) and interleukin 1 beta (IL-1b)[4]. So, in this work we examined the antipyretic effect of
silymarin, which may show another property of this magic
plant especially that many authors didn't evaluate this effect
before on Silymarin.
A signiﬁcant anti-inﬂammatory effect of silymarin has been
described lately. Silymarin exhibits many effects such as inhi-
bition of neutrophil migration, downregulation of Kupffer cells,
decline of leukotriene production and utilization of prostaglan-
dins [3,5,6]. The anti-inﬂammatory effect of silymarin is not well
known up till now; it could be associated to the decrease of the
production of nuclear factor-kappa (NF-kB), which controls the
synthesis of several genes that plays an important role in the
inﬂammatory progression [4,7].
High percentage of the phenolic compounds are known to
have antinociceptive properties [8–10]. So, in this study we
evaluated the antinociceptive effect of silymarin at two doses
level (50 and 100 mg/kg) using hot plate method, which up
till now no authors estimates it directly.an open access article under the CC BY-NC-ND
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changes of membrane lipids (cholesterol and phospholipids),
this may effect lipoprotein excretion and uptake [11]. Silymarin
reduces plasma levels of low density lipoprotein (LDL)
cholesterol in hyperlipidaemic rats [11]. Also, it is able to
normalize the increase in plasma lipids observed and to
antagonize the reduction in serum free fatty acids induced by
thioacetamide. It is known that silibinin is able to provoke the
increase in lipids and triglycerides produced in the liver and to
activate fatty acid b-oxidation [11], it was evident that
silymarin increases LDL binding to hepatocytes, an important
factor for the reduction of LDL in plasma [11]. Moreover,
silymarin may reduce triglyceride production in the liver [11].
So, we aimed by this study to spotlight on the possible
antipyretic effect of silymarine and on the evaluation of PGE2,
TNF-a and IL-1b which they play a major role in the inﬂam-
mation process.
2. Materials and methods
2.1. Animals
Adult male Albino Sprague Dawely rats and mice weighing
80–90 g and 18–20 g respectively were obtained from the Na-
tional Research Center Animal Laboratory (Giza, Egypt) and
were accommodated in standard polypropylene cages and kept
under constant environmental conditions and equal light–dark
cycles. The animals were fed commercially available normal
standard diet and water ad libitum. The investigations were
carried in accordance to the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and
Institutional Animal Ethical Committee and complies with the
guidelines from the Canadian Council on Animal Care.
2.2. Plant material
Silymarin was purchased from Sigma–Aldrich Co. (St Louis,
MO, USA).
2.3. Drugs and chemicals
ELISA technique was carried out using the corresponding
ELISA rat kits for the assessment of TNF-a, IL-1b and PGE2
levels in serum (Pierce, Rockford, USA).
2.4. Standard drugs used as a control
Paracetamol was purchased from Misr Company for pharma-
ceutical industries,Giza, Egypt.While, indomethacinwas obtained
from El Kahera pharmaceutical industrial company, Giza, Egypt.
Aspirin from was obtained Bayer Limited Egypt LLC, Cairo,
Egypt. Atorvastatin was purchased from Alexandria pharmaceu-
tical company, Alexandria, Egypt. Synchron CX5 auto-analyzer
(Beckman Instruments INC, Brea, USA) was used for measuring
serum total cholesterol, triglycerides, LDL and high density lipo-
protein (HDL). Plant material and drugs were given orally.
2.5. Antipyretic test
Rats were divided into 4 groups (n = 6). Body temperature of
each rat was measured from the rectum using thermometer. Ratswere injected intramuscularly with pyrogenic dose of Brewer's
yeast (1 mL/100 g body weight of 44% yeast suspension in
saline) [12,13]. Temperature was measured after 18 h from
injection and considered as zero time. Two doses of silymarin
(50 and 100 mg/kg), paracetamol (50 mg/kg) (positive control)
and saline (negative control) were administered once orally by
gastric tube to each group rats respectively and the
temperature was measured after 1 and 2 h interval [12–14].
2.6. Anti-inﬂammatory test
This test was carried out by carrageenan induced rat paw
edema [15]. Rats were divided into 4 groups (n = 6), 2 doses of
silymarin (50 and 100 mg/kg), indomethacine (20 mg/kg)
(positive control) and saline (negative control) were
administered once orally by gastric tube [16]. All rats were
injected with 0.1 mL of 1% carrageenan solution in saline at
the subplanter area of the right hind paw after 1 h from
silymarin and indomethacine administration. Each rat its
paw thickness was measured by planimeter and blood
samples were collected from retro orbital plexus vein of
anesthetized rats and centrifuged at 5000 r/min at 4

C for
10 min using Hermle cooling bench top centrifuge Z 323 K
(Japan) to separate serum samples for estimation of PGE2,
TNF-a and IL-1b using plate reader (Tecan Spectra Classic
Plate Reader, USA) before carrageenan administration. After
administration of carrageenan the paw thickness of each rat
was measured by planimeter every 1 h for 4 h, after 4 h
serum samples were collected again for estimation of PGE2,
TNF-a and IL-1b. Edema rate, inhibition, potency were
calculated as follows [17]:
Edema ð%Þ = Control thicknessmean − Treated thicknessmean
Control thicknessmean
×100
Inhibition ð%Þ
=
Control edema ð%Þ mean − Treated edema ð%Þ mean
Control edema ð%Þ mean × 100
Potency ð%Þ
= 100−
Inhibition ð%Þ indomethacine − Inhibition ð%Þ treated group
Inhibition ð%Þ indomethacine
×100
2.7. Antinociceptive test
This test was carried out by hot plate method for determination
of silymarin analgesic effect [18]. Mice were adapted for 3
consecutive days before the test by putting them in hot plate
device adapted at room temperature for 15 min [13]. Latency to
show analgesic response, like licking the paws or jumping out
the hot plate was recorded at 30 and 60 min after administration
of 2 doses of silymarin (50 and 100 mg/kg), aspirin (200 mg/kg)
(positive control) and saline (negative control) orally by gastric
tube [19]. Response time for thermal pain was recorded before
administration of silymarin and drug (0 time).
2.8. Antihyperlipidemic test
Hyperlipidemia was induced using high fat diet for 2 months
[20]. This diet formula was prepared by mixing normal fat diet
Table 3
Effect of silymarin on PGE2, TNF-a and IL-1b levels in serum after 4 h
of carrageenan administration in Albino rats (ng/L).
Groups PGE2 TNF-a IL-1b
Normal 201.65 ± 18.61 9.81 ± 0.78 38.51 ± 2.95
Control
(1 mL saline)
710.18 ± 45.66† 55.41 ± 2.85† 101.75 ± 7.81†
Indomethacine
(20 mg/kg)
386.85 ± 19.75*† 18.33 ± 1.01*† 53.48 ± 4.03*†
Silymarine
(50 mg/kg)
592.55 ± 33.41*† 41.46 ± 3.11*† 82.86 ± 6.66*†
Silymarine
(100 mg/kg)
442.00 ± 26.20*† 28.11 ± 1.95*† 67.91 ± 5.38*†
Values are means ± SE of 6 animals. As compared with control positive
(*) and normal (†) groups (One-way ANOVA followed by Tukey post
hoc test) at P < 0.05.
Table 4
Antinociceptive effect of silymarin in Albino mice (seconds).
Groups Response time
Zero time 30 min 60 min
Control (1 mL saline) 11.18 ± 0.36 11.23 ± 0.37 11.35 ± 0.33
Aspirin (200 mg/kg) 11.41 ± 0.31 15.33 ± 0.22* 17.90 ± 0.30*
Silymarine (50 mg/kg) 11.55 ± 0.46 13.70 ± 0.20* 16.26 ± 0.15*
Silymarine (100 mg/kg) 11.38 ± 0.44 14.23 ± 0.14* 17.76 ± 0.15*
Values are means ± SE of 6 animals. As compared with normal control
(*) group (One-way ANOVA followed by Tukey post hoc test) at
P < 0.05.
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chloride, 20% lactose, 2% sodium cholate, 20% hydrogenated
vegetable oil, 20% sucrose and 5% cholesterol). Rats were
divided into 4 groups (n = 10), 2 groups were received 50 and
100 mg/kg of silymarin respectively for 2 weeks, 1 group was
received atorvastatin (1 mg/kg) (positive control) twice a week
for 2 weeks [21] and 1 group was received saline (negative
control) for 2 weeks. All drugs were administered orally using
gastric tube and all groups received normal fat diet during 2
weeks of treatment. After 2 weeks of treatment and after
overnight fasting, blood samples were collected from retro-
orbital plexus vein of anesthetized rats and centrifuged to
separate serum samples for estimation of total cholesterol,
triglycerides, HDL and LDL using Synchron CX5 auto-
analyzer (Beckman Instruments INC, Brea, USA).
2.9. Statistical analysis
The differences between groups were tested for signiﬁcance
using ANOVA, followed by Tukey post hoc test determined by
SPSS software program, version 21. Values are expressed as
mean ± SE. The level of statistical signiﬁcance was taken at
P < 0.05.
3. Results
Table 1 revealed the antipyretic effect of silymarin (50 and
100 mg/kg) was signiﬁcant in comparison with control positive
group. Both doses of silymarin showed a dose dependent effect
manner, which was appeared in lowering the body temperature
(100 mg/kg silymarin more effective than the 50 mg/kg dose).
But, paracetamol (standard drug) showed a more powerful effect
than the two doses of silymarin.
The anti-inﬂammatory effect of both doses of silymarin
(Table 2) was elucidated in the signiﬁcant decline of rat paw
edema% compared with positive control group which is re-
ﬂected also on the percentage of inhibition and the percentage ofTable 1
Antipyretic effect of silymarin in Albino rats.
Groups Body temperature (

C)
Zero time 1 h 2 h
Control (1 mL saline) 38.50 ± 0.13 39.02 ± 0.04 39.20 ± 0.11
Paracetamol (50 mg/kg) 38.70 ± 0.10 37.96 ± 0.08* 37.60 ± 0.05*
Silymarine (50 mg/kg) 38.75 ± 0.12 38.40 ± 0.07* 38.15 ± 0.16*
Silymarine (100 mg/kg) 38.70 ± 0.10 38.20 ± 0.08* 37.80 ± 0.11*
Values are means ± SE of 6 animals. As compared with normal control
(*) group (One-way ANOVA followed by Tukey post hoc test) at
P < 0.05.
Table 2
Anti-inﬂammatory effect of silymarin in Albino rats (%).
Groups Edema Inhibition Potency
Control (1 mL saline) 15.16 ± 0.01 – –
Indomethacine (20 mg/kg) 3.36 ± 0.30* 77.84 100.0
Silymarine (50 mg/kg) 11.14 ± 0.01* 26.52 34.1
Silymarine (100 mg/kg) 7.12 ± 0.30* 53.03 68.1
Values are means ± SE of 6 animals. As compared with control positive
(*) group (One-way ANOVA followed by Tukey post hoc test) at
P < 0.05.potency. Both doses of silymarin showed a dose dependent ef-
fect manner (100 mg/kg silymarin more effective than the
50 mg/kg dose). In addition, the signiﬁcant decrease in PGE2,
TNF-a and IL-1b 4 h after administration of carrageenan in
comparison with positive control group (Table 3). Both doses of
silymarin showed a dose dependent effect manner (100 mg/kg
silymarin more effective than the 50 mg/kg dose). Moreover,
indomethacine (standard drug) was more potent in its anti-Table 5
Antihyperlipidemic effect of 2 weeks of administration of silymarin on
total cholesterol, triglycerides, HDL and LDL after 2 months of high fat
diet in Albino rats (mg/dL).
Group Parameters Time
Zero 2 weeks
Control (1 mL saline) Cholesterol 175.66 ± 2.9 170.59 ± 2.1
Triglycerides 161.44 ± 1.8 158.88 ± 2.3
HDL 15.05 ± 0.9 15.41 ± 0.8
LDL 132.32 ± 2.2 128.21 ± 1.9
Atorvastatin (1 mg/kg) Cholesterol 181.28 ± 5.4 108.49 ± 4.2*
Triglycerides 156.12 ± 3.4 96.76 ± 1.9*
HDL 14.08 ± 0.3 30.77 ± 1.1*
LDL 128.84 ± 4.1 71.75 ± 0.7*
Silymarin (50 mg/kg) Cholesterol 168.44 ± 3.9 144.61 ± 5.6*
Triglycerides 157.88 ± 5.4 120.91 ± 1.6*
HDL 15.55 ± 0.4 22.52 ± 0.4*
LDL 129.07 ± 3.5 101.11 ± 1.4*
Silymarin (100 mg/kg) Cholesterol 172.35 ± 5.1 120.38 ± 5.5*
Triglycerides 163.41 ± 6.1 130.13 ± 4.5*
HDL 13.96 ± 0.7 27.62 ± 0.2*
LDL 135.86 ± 4.1 90.22 ± 2.1*
Values are means ± SE of 10 animals. As compared with zero time (*)
(One-way ANOVA followed by Tukey post hoc test) at P < 0.05.
Table 6
Silymarin effect on body weight in Albino rats (g).
Groups Body weight
Zero time 2 months 2 weeks
Post treatment
Control
(1 mL saline)
82.71 ± 2.32 286.73 ± 8.68* 278.26 ± 6.77
Atorvastatin
(1 mg/kg)
79.52 ± 1.43 293.65 ± 9.40* 190.35 ± 4.11†
Silymarine
(50 mg/kg)
80.93 ± 3.11 281.88 ± 5.33* 253.64 ± 3.56†
Silymarine
(100 mg/kg)
81.44 ± 2.22 288.59 ± 7.86* 221.75 ± 2.85†
Values are means ± SE of 10 animals. As compared with zero time (*)
group, 2 months (†) group (One-way ANOVA followed by Tukey post
hoc test) at P < 0.05.
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kines) than the two doses of silymarin.
Table 4 showed the signiﬁcance of antinociceptive activity of
both doses of silymarin compared to the normal control group
after 30 and 60 min of silymarin administration, which is re-
ﬂected on the increase of the response time to thermal pain. Both
doses of silymarin showed a dose dependent effect manner
(100 mg/kg silymarin more effective than the 50 mg/kg dose).
However, aspirin (standard) drug represented more obvious
antinociceptive activity than the both doses of silymarin.
Both doses of silymarin showed a signiﬁcant anti-
hyperlipidemic effect (Table 5), which was reﬂected on the
signiﬁcant decrease in cholesterol, triglycerides and LDL serum
levels in comparison with zero time group. While silymarin
showed a signiﬁcant increase in HDL serum level in hyper-
lipidemic rats in comparison with zero time group. By the same
way, both doses of silymarin showed a dose dependent effect
manner (100 mg/kg silymarin more effective than the 50 mg/kg
dose). But the effect of atorvastatin (standard drug) was stronger
than the both doses silymarin.
The signiﬁcant decline in the body weight of the treated
hyperlipidemic animals’ was contributed to the effect of both
doses of silymarin (Table 6) compared with the 2 months high
fat diet group. And both doses of silymarin showed a dose
dependent effect manner (100 mg/kg silymarin more effective
than the 50 mg/kg dose). However, atorvastatin (standard drug)
was more effective than both doses of silymarin.
4. Discussion
Silymarin, an extract from the milk thistle plant seeds, has
been used for centuries against liver diseases. Silymarin is a
blend of ﬂavonolignans: silybin-A, silybin-B, isosilybin-A,
isosilybin-B, silychristin, silydianin and isosilychristin and one
ﬂavonoid named taxifolin. Silymarin has antioxidant, immuno-
modulatory, anti-proliferative and anti-viral activities although
its mechanism of action is incompletely known till date [22–24].
Earlier studies have contained within inadequate data and
consumption of changeable doses, making it difﬁcult to
compare results between readings.
In our study, silymarin showed a novel signiﬁcant antipyretic
effect against pyrogenic dose of brewer's yeast. This pathogenic
dose is caused by massive production of PGE2 which isresponsible for fever production [25]. Silymarin dose-
dependently suppressed the TNF-a, IL-1b and PGE2. Consis-
tent with these results, the mRNA expression of IL-1b and
cyclooxygenase-2 was also completely blocked by silymarin.
Moreover, activity of NF-kB was also inhibited by silymarin as
stated by another author [26].
Also, silymarin elucidated an anti-inﬂammatory action
against carrageenan induced inﬂammation. Edema occurred
through 2 phases, the ﬁrst one occurred due to the release of
histamine and cyclooxygenase ingredients, while the second
one, occurred due to the release of prostaglandins, proteases and
lysosomes [13,27]. Silymarin prevents the release of inﬂammatory
mediators, such as TNF-a, IL-1b, PGE2 and nitric oxide [26].
Authors found that silymarin in a dose-dependent manner
declined the production of inducible nitric oxide synthase. It was
suggested that the inhibitory effect of silymarin was arbitrated to
the inhibition of NF-kB activation [28,29].
Antinociceptive effect of silymarin was clear against normal
control group like the same effect if its anti-inﬂammatory effect
due to its inhibition of prostaglandins (PGE2 and prostaglandin
F2) (pain inducers) [30–32].
The two doses of silymarin exhibited a signiﬁcant anti-
hyperlipidemic activity reﬂected on the signiﬁcant decline of
cholesterol, triglycerides, LDL and body weight and a signiﬁ-
cant increase if HDL in comparison with zero time group in a
dose dependent manner. This action due to the inﬂuence of the
increased cellular permeability which is closely associated with
changes of membrane lipids [33]. This proposes that silymarin
may stimulate lipoprotein secretion and uptake. Also,
silymarin and silibinin decrease the synthesis and turnover of
phospholipids in the liver. Furthermore, silibinin is able to
inhibit phospholipid synthesis [11]. In addition, silibinin
induces phosphatidylcholine synthesis and increases the
activity of cholinephosphate cytidyltransferase in rat liver in
normal conditions [33]. Silymarin, also stimulate fatty acid b-
oxidation and may reduce triglyceride synthesis in the liver [1].
This experiment was planned to clarify the antipyretic, anti-
inﬂammatory, antinociceptive and antihyperlipidemic effects of
silymarin in two doses forms to prove which dose is more
powerful and if its action is in dose dependent manner or not,
especially silymarin used in worldwide and in Egypt as a natural
liver support in many cases of liver diseases. So, we made this
study to evaluate other pharmacological actions and beneﬁts of
silymarin.
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